StockData
Palisade Bio, Inc. logo

Palisade Bio, Inc. (PALI) stock

PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$1.01−0.02 (-1.94%)

Close on Nov 17, 2026Market cap $176.01MP/E –Yield –

Palisade Bio pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Palisade Bio's pe ratio was 0.8× on Oct 31, 2022.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Oct 31, 20220.8×–

More Palisade Bio figures

See a number that looks wrong?